Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.37 |
| ▸ | AGTR2 | P50052 | 3/20 | 0.37 |
| ▸ | EDNRA | P25101 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4010058 | 0.93 | PPARG (0.50) | PPARGACHEAGTR1AGTR2EDNRA | |
| SCHEMBL1892450 | 0.90 | PPARG (0.49) | PPARGACHEAGTR1AGTR2EDNRA | |
| SCHEMBL4016998 | 0.88 | PPARG (0.45) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL4011296 | 0.85 | PPARG (0.47) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL4010050 | 0.84 | PPARG (0.49) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL4010964 | 0.84 | PPARG (0.46) | PPARGACHEAGTR1AGTR2EDNRA | |
| SCHEMBL4013058 | 0.84 | PPARG (0.46) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL1893340 | 0.83 | PPARG (0.51) | PPARGACHEAGTR1 | |
| SCHEMBL1892271 | 0.82 | PPARG (0.50) | PPARGACHEAGTR1AGTR2 | |
| SCHEMBL4012027 | 0.81 | PPARG (0.63) | PPARGACHEAGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009133970-A1 | CRYSTALLINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-05 | — | — | WO | disclosed |
| EP-2074117-A2 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008062905-A2 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-05-29 | — | — | WO | disclosed |